Exact Mass: 476.2311
Exact Mass Matches: 476.2311
Found 500 metabolites which its exact mass value is equals to given mass value 476.2311
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Loperamide
Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines; it does not affect the central nervous system like other opioids; Loperamide usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; Treatment should be avoided in the presence of fever or if the stool is bloody. Treatment is not recommended for patients who could suffer detrimental effects from rebound constipation. If there is a suspicion of diarrhea associated with organisms that can penetrate the intestinal walls, such as E. coli O157:H7 or salmonella, loperamide is contraindicated; Loperamide, usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; it does not affect the central nervous system like other opioids; One of the long-acting synthetic antidiarrheals; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally; Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines [HMDB] Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines; it does not affect the central nervous system like other opioids; Loperamide usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; Treatment should be avoided in the presence of fever or if the stool is bloody. Treatment is not recommended for patients who could suffer detrimental effects from rebound constipation. If there is a suspicion of diarrhea associated with organisms that can penetrate the intestinal walls, such as E. coli O157:H7 or salmonella, loperamide is contraindicated; Loperamide, usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; it does not affect the central nervous system like other opioids; One of the long-acting synthetic antidiarrheals; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally; Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals KEIO_ID L047; [MS2] KO009036 KEIO_ID L047
Retinoyl b-glucuronide
Retinoyl beta-glucuronide is a naturally occurring, biologically active metabolite of vitamin A. Although retinoyl beta-glucuronide is regarded as a detoxification product of retinoic acid, it plays several roles in the functions of vitamin A. It can serve as a source of retinoic acid, and it may be a vehicle for transport of retinoic acid to target tissues. Topically applied retinoyl beta-glucuronide is comparable in efficacy to retinoic acid in the treatment of acne in humans, without the same side effects. Retinoyl beta-glucuronide may or may not be teratogenic, depending on the mode of administration and the species in which it is used. It may be a valuable therapeutic compound for the treatment of skin disorders and certain types of cancers. [HMDB] Retinoyl beta-glucuronide is a naturally occurring, biologically active metabolite of vitamin A. Although retinoyl beta-glucuronide is regarded as a detoxification product of retinoic acid, it plays several roles in the functions of vitamin A. It can serve as a source of retinoic acid, and it may be a vehicle for transport of retinoic acid to target tissues. Topically applied retinoyl beta-glucuronide is comparable in efficacy to retinoic acid in the treatment of acne in humans, without the same side effects. Retinoyl beta-glucuronide may or may not be teratogenic, depending on the mode of administration and the species in which it is used. It may be a valuable therapeutic compound for the treatment of skin disorders and certain types of cancers. D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
Austalide H
Austalide H is a mycotoxin of the food storage mould (Aspergillus ustus Mycotoxin of the food storage mould (Aspergillus ustus)
1-O-all-trans-retinoyl-beta-glucuronic Acid
1-O-all-trans-retinoyl-beta-glucuronic Acid is classified as a member of the Diterpene glycosides. Diterpene glycosides are diterpenoids in which an isoprene unit is glycosylated. 1-O-all-trans-retinoyl-beta-glucuronic Acid is considered to be practically insoluble (in water) and acidic. 1-O-all-trans-retinoyl-beta-glucuronic Acid is an isoprenoid lipid molecule
All-trans-retinoyl B-glucuronide
2-Pyrimidinamine, N-ethyl-4-(4-(3-fluorophenyl)-3,6-dihydro-1(2H)-pyridinyl)-6-methyl-N-(4-(1-methylethyl)-2-(methylthio)phenyl)-
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists
Nalfurafine
Methyl 1-benzoyl-20-hydroxy-17-methoxyaspidospermidin-21-oate #
(11E)-6alpha-Acetoxy-7beta-isobutyryloxy-1beta,8beta-dihydroxy-4(18),11,13-neoclerodatrien-15,16-olide|Scuterulein D
9alpha-(2-methyl-butyryloxy)-repandanolide-8-O-angelate|9alpha-<2-methyl-butyryloxy>-repandanolide-8-O-angelate
(1S,2R,6S,9R)-2,7-bis(angeloyloxy)-6,9-epoxy-11-hydroxy-6-methoxybisabola-3,10(15)-dien-5-one|2-hydroxy-1-{[(2R,3aS,4R,7aS)-2,3,3a,4,7,7a-hexahydro-7a-methoxy-6-methyl-4-{[(2Z)-2-methylbut-2-enoyl]oxy}-3-methylidene-7-oxo-1-benzofuran-2-yl]methyl}-2-methylpropyl (2Z)-2-methylbut-2-enoate
7beta-hydroxy-6beta,14beta,15beta-triacetoxy-7alpha,20-epoxy-ent-kaur-16-ene|hebeirubescensin L
(+)-angelicoidenol 2-O-[6-O-S-3-hydroxy-3-methylglutaryl]-beta-D-glucopyranoside|zingiberoside C
limonen-10-ol 10-O-beta-D-glucopyranosyl-(1-2)-beta-D-glucopyranoside
3beta,6beta-diangeloyloxy-10alpha-hydroxy-8alpha-methoxyeremophilenolide|3??,6??-Diangeloyloxy-10??-hydroxy-8??-methoxyeremophilenolide
Asp Ser Gln Lys
Ser Asn Thr Arg
Thr Asn Asp Lys
loperamide
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals CONFIDENCE standard compound; INTERNAL_ID 2504 CONFIDENCE standard compound; INTERNAL_ID 8489
Ala Lys Met Gln
Ala Lys Gln Met
Ala Met Lys Gln
Ala Met Gln Lys
Ala Gln Lys Met
Ala Gln Met Lys
Cys Glu Ile Ile
Cys Glu Ile Leu
Cys Glu Leu Ile
Cys Glu Leu Leu
Cys Ile Glu Ile
Cys Ile Glu Leu
Cys Ile Ile Glu
Cys Ile Lys Asn
Cys Ile Leu Glu
Cys Ile Asn Lys
Cys Lys Ile Asn
Cys Lys Leu Asn
Cys Lys Asn Ile
Cys Lys Asn Leu
Cys Lys Gln Val
Cys Lys Val Gln
Cys Leu Glu Ile
Cys Leu Glu Leu
Cys Leu Ile Glu
Cys Leu Lys Asn
Cys Leu Leu Glu
Cys Leu Asn Lys
Cys Asn Ile Lys
Cys Asn Lys Ile
Cys Asn Lys Leu
Cys Asn Leu Lys
Cys Gln Lys Val
Cys Gln Val Lys
Cys Val Lys Gln
Cys Val Gln Lys
Asp Phe Pro Val
Asp Phe Val Pro
Asp Ile Met Val
Asp Ile Val Met
Asp Lys Asn Thr
Asp Lys Gln Ser
Asp Lys Ser Gln
Asp Lys Thr Asn
Asp Leu Met Val
Asp Leu Val Met
Asp Met Ile Val
Asp Met Leu Val
Asp Met Val Ile
Asp Met Val Leu
Asp Asn Lys Thr
Asp Asn Thr Lys
Asp Pro Phe Val
Asp Pro Val Phe
Asp Gln Lys Ser
Asp Gln Ser Lys
Asp Ser Lys Gln
Asp Thr Lys Asn
Asp Thr Asn Lys
Asp Val Phe Pro
Asp Val Ile Met
Asp Val Leu Met
Asp Val Met Ile
Asp Val Met Leu
Asp Val Pro Phe
Glu Cys Ile Ile
Glu Cys Ile Leu
Glu Cys Leu Ile
Glu Cys Leu Leu
Glu Ile Cys Ile
Glu Ile Cys Leu
Glu Ile Ile Cys
Glu Ile Leu Cys
Glu Lys Asn Ser
Glu Lys Ser Asn
Glu Leu Cys Ile
Glu Leu Cys Leu
Glu Leu Ile Cys
Glu Leu Leu Cys
Glu Met Val Val
Glu Asn Lys Ser
Glu Asn Ser Lys
Glu Ser Lys Asn
Glu Ser Asn Lys
Glu Val Met Val
Glu Val Val Met
Phe Asp Pro Val
Phe Asp Val Pro
Phe Pro Asp Val
Phe Pro Val Asp
Phe Val Asp Pro
Phe Val Pro Asp
Gly Lys Ser Trp
Gly Lys Trp Ser
Gly Ser Lys Trp
Gly Ser Trp Lys
Gly Trp Lys Ser
Gly Trp Ser Lys
Ile Cys Glu Ile
Ile Cys Glu Leu
Ile Cys Ile Glu
Ile Cys Lys Asn
Ile Cys Leu Glu
Ile Cys Asn Lys
Ile Asp Met Val
Ile Asp Val Met
Ile Glu Cys Ile
Ile Glu Cys Leu
Ile Glu Ile Cys
Ile Glu Leu Cys
Ile Ile Cys Glu
Ile Ile Glu Cys
Ile Leu Cys Glu
Ile Leu Glu Cys
Ile Met Asp Val
Ile Met Val Asp
Ile Val Asp Met
Ile Val Met Asp
Lys Asp Asn Thr
Lys Asp Gln Ser
Lys Asp Ser Gln
Lys Asp Thr Asn
Lys Glu Asn Ser
Lys Glu Ser Asn
Lys Gly Ser Trp
Lys Gly Trp Ser
Lys Asn Asp Thr
Lys Asn Glu Ser
Lys Asn Ser Glu
Lys Asn Thr Asp
Lys Gln Asp Ser
Lys Gln Ser Asp
Lys Ser Asp Gln
Lys Ser Glu Asn
Lys Ser Gly Trp
Lys Ser Asn Glu
Lys Ser Gln Asp
Lys Ser Trp Gly
Lys Thr Asp Asn
Lys Thr Asn Asp
Lys Trp Gly Ser
Lys Trp Ser Gly
Leu Cys Glu Ile
Leu Cys Glu Leu
Leu Cys Ile Glu
Leu Cys Leu Glu
Leu Asp Met Val
Leu Asp Val Met
Leu Glu Cys Ile
Leu Glu Cys Leu
Leu Glu Ile Cys
Leu Glu Leu Cys
Leu Ile Cys Glu
Leu Ile Glu Cys
Leu Leu Cys Glu
Leu Leu Glu Cys
Leu Met Asp Val
Leu Met Val Asp
Leu Val Asp Met
Leu Val Met Asp
Met Asp Ile Val
Met Asp Leu Val
Met Asp Val Ile
Met Asp Val Leu
Met Glu Val Val
Met Ile Asp Val
Met Ile Val Asp
Met Leu Asp Val
Met Leu Val Asp
Met Val Asp Ile
Met Val Asp Leu
Met Val Glu Val
Met Val Ile Asp
Met Val Leu Asp
Met Val Val Glu
Asn Asp Lys Thr
Asn Asp Thr Lys
Asn Glu Lys Ser
Asn Glu Ser Lys
Asn Lys Asp Thr
Asn Lys Glu Ser
Asn Lys Ser Glu
Asn Lys Thr Asp
Asn Arg Ser Thr
Asn Arg Thr Ser
Asn Ser Glu Lys
Asn Ser Lys Glu
Asn Ser Arg Thr
Asn Ser Thr Arg
Asn Thr Asp Lys
Asn Thr Lys Asp
Asn Thr Arg Ser
Asn Thr Ser Arg
Pro Asp Phe Val
Pro Asp Val Phe
Pro Phe Asp Val
Pro Phe Val Asp
Pro Pro Thr Tyr
Pro Pro Tyr Thr
Pro Thr Pro Tyr
Pro Thr Tyr Pro
Pro Val Asp Phe
Pro Val Phe Asp
Pro Tyr Pro Thr
Pro Tyr Thr Pro
Gln Asp Lys Ser
Gln Asp Ser Lys
Gln Lys Asp Ser
Gln Lys Ser Asp
Gln Gln Thr Thr
Gln Arg Ser Ser
Gln Ser Asp Lys
Gln Ser Lys Asp
Gln Ser Arg Ser
Gln Ser Ser Arg
Gln Thr Gln Thr
Gln Thr Thr Gln
Arg Asn Ser Thr
Arg Asn Thr Ser
Arg Gln Ser Ser
Arg Ser Asn Thr
Arg Ser Gln Ser
Arg Ser Ser Gln
Arg Ser Thr Asn
Arg Thr Asn Ser
Arg Thr Ser Asn
Ser Asp Lys Gln
Ser Asp Gln Lys
Ser Glu Lys Asn
Ser Glu Asn Lys
Ser Gly Lys Trp
Ser Gly Trp Lys
Ser Lys Asp Gln
Ser Lys Glu Asn
Ser Lys Gly Trp
Ser Lys Asn Glu
Ser Lys Gln Asp
Ser Lys Trp Gly
Ser Asn Glu Lys
Ser Asn Lys Glu
Ser Asn Arg Thr
Ser Gln Asp Lys
Ser Gln Lys Asp
Ser Gln Arg Ser
Ser Gln Ser Arg
Ser Arg Asn Thr
Ser Arg Gln Ser
Ser Arg Ser Gln
Ser Arg Thr Asn
Ser Ser Gln Arg
Ser Ser Arg Gln
Ser Thr Asn Arg
Ser Thr Arg Asn
Ser Trp Gly Lys
Ser Trp Lys Gly
Thr Asp Lys Asn
Thr Asp Asn Lys
Thr Lys Asp Asn
Thr Lys Asn Asp
Thr Asn Lys Asp
Thr Asn Arg Ser
Thr Asn Ser Arg
Thr Pro Pro Tyr
Thr Pro Tyr Pro
Thr Gln Gln Thr
Thr Gln Thr Gln
Thr Arg Asn Ser
Thr Arg Ser Asn
Thr Ser Asn Arg
Thr Ser Arg Asn
Thr Thr Gln Gln
Thr Tyr Pro Pro
Val Asp Phe Pro
Val Asp Ile Met
Val Asp Leu Met
Val Asp Met Ile
Val Asp Met Leu
Val Asp Pro Phe
Val Glu Met Val
Val Glu Val Met
Val Phe Asp Pro
Val Phe Pro Asp
Val Ile Asp Met
Val Ile Met Asp
Val Leu Asp Met
Val Leu Met Asp
Val Met Asp Ile
Val Met Asp Leu
Val Met Glu Val
Val Met Ile Asp
Val Met Leu Asp
Val Met Val Glu
Val Pro Asp Phe
Val Pro Phe Asp
Val Val Glu Met
Val Val Met Glu
Trp Gly Lys Ser
Trp Gly Ser Lys
Trp Lys Gly Ser
Trp Lys Ser Gly
Trp Ser Gly Lys
Trp Ser Lys Gly
Tyr Pro Pro Thr
Tyr Pro Thr Pro
Tyr Thr Pro Pro
Austalide H
(7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol
1H-Indole-1-carboxylic acid, 5-[bis[(1,1-dimethylethoxy)carbonyl]amino]-2-borono-, 1-(1,1-dimethylethyl) ester (9CI)
8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one
Nalfurafine
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist
Flunisolide acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
(E)-N-[3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide
N-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-4,6-di(piperidin-1-yl)-1,3,5-triazin-2-amine
N-[(1S,3R,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
1-(2,5-difluorophenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2,5-difluorophenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2,5-difluorophenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2,5-difluorophenyl)-3-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(1S,9R,10R,11R)-12-[(2-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-N-propyl-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[[(4R,5S)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclobutanecarboxamide
N-[[(4S,5R)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-cyclopropyl-N-methylacetamide
1-(2,5-difluorophenyl)-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2,5-difluorophenyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(1S,3S,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[[(4S,5R)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclobutanecarboxamide
N-[[(4S,5R)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclobutanecarboxamide
N-[[(4S,5S)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-cyclopropyl-N-methylacetamide
N-[[(4R,5S)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-cyclopropyl-N-methylacetamide
1-(2,5-difluorophenyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(1R,3R,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
(1R,9S,10S,11S)-12-[(2-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-N-propyl-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
1,4-Bis(methyldiphenylsilyl)-2,3-dimethyl-2-butene
Retinoyl glucuronide
A retinoid that is retinoic acid in which the carboxy proton has been replaced by a beta-D-glucuronyl residue.
6-[3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
9-cis-Retinoyl-beta-D-glucuronide
A retinoid that is 9-cis-retinoic acid in which the carboxy proton has been replaced by a beta-D-glucuronyl group. It is a major metabolite of 9-cis-retinoic acid.
(1s,2s,5r,7r,8s,9s,10s,11r,15r)-10,15-bis(acetyloxy)-9-hydroxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-yl acetate
(1s,2s)-1-[(1r,4as,9r,11ar)-1-(acetyloxy)-9-hydroxy-7-methyl-11-methylidene-1h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-1-(acetyloxy)-4-methylpent-3-en-2-yl acetate
[6,7-bis(acetyloxy)-4-[2-(furan-3-yl)ethyl]-5,7a,7b-trimethyl-hexahydro-1ah-naphtho[1,2-b]oxiren-4-yl]methyl acetate
methyl 2-[(1s,2s,4ar,5r,8s,8as)-1,5,8-trihydroxy-4a-methyl-8-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-octahydronaphthalen-2-yl]prop-2-enoate
(2s)-1-[(2r,3as,4r,7as)-7a-methoxy-6-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-3-methylidene-7-oxo-3a,4-dihydro-2h-1-benzofuran-2-yl]-3-hydroxy-3-methylbutan-2-yl (2z)-2-methylbut-2-enoate
10,15-bis(acetyloxy)-9-hydroxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-yl acetate
(1r,2r,3r,4s,6s,9s,10s,11s,13r)-2,6-bis(acetyloxy)-11-hydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
(2r,3r,4r,7s,10r,11r,14s)-2,10-bis(acetyloxy)-7-hydroxy-4,14,15,15-tetramethyl-8-methylidene-13-oxotetracyclo[9.3.1.0¹,⁹.0⁴,⁹]pentadecan-3-yl acetate
(1s)-1-[(1r,4as,9r,11as)-1,9-bis(acetyloxy)-7-methyl-11-methylidene-1h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-2-[(2r)-3,3-dimethyloxiran-2-yl]ethyl acetate
10-{[7a-hydroxy-3-(1-hydroxy-4-methylpent-3-en-1-yl)-4-methoxy-3-methyl-hexahydro-2-benzofuran-5-yl]oxy}-10-oxodeca-2,4,6,8-tetraenoic acid
(1r,2s,3r,4r,4as,5r,8ar)-1-(acetyloxy)-3,5-dihydroxy-3,4,8a-trimethyl-8-methylidene-4-[(1e)-2-(5-oxo-2h-furan-3-yl)ethenyl]-hexahydronaphthalen-2-yl butanoate
(1s,3r,4r,7s,8z,12r,13s,14s)-14-(acetyloxy)-3-hydroxy-4,9,13,17-tetramethyl-2,5-dioxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-12-yl butanoate
3β,6β-diangeloyloxy-10α-hydroxy-8α-me-thoxyeremophilenolide
{"Ingredient_id": "HBIN008104","Ingredient_name": "3\u03b2,6\u03b2-diangeloyloxy-10\u03b1-hydroxy-8\u03b1-me-thoxyeremophilenolide","Alias": "NA","Ingredient_formula": "C26H36O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5355","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
adenanthin c
{"Ingredient_id": "HBIN014674","Ingredient_name": "adenanthin c","Alias": "NA","Ingredient_formula": "C26H36O8","Ingredient_Smile": "CC(=O)OC1CC2CC3(C1C4(C(CC3OC(=O)C)C(C(CC4OC(=O)C)O)(C)C)C)C(=O)C2=C","Ingredient_weight": "476.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "607","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10928875","DrugBank_id": "NA"}